Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Ann Hematol ; 100(12): 2909-2917, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34432101

ABSTRACT

Tissue iron overload is a life-threatening scenario in children with transfusion-dependent ß-thalassemia major, miRNAs that are involved in iron hemostasis could serve as therapeutic targets for control of iron overload. We aimed to find out the association between three iron-related miRNAs "miR-let-7d, miR-122, and miR-200b" and excess iron in tissues, in transfusion-dependent ß-thalassemia major patients. Circulating miRNA expressions are measured in peripheral blood (PB) samples using qPCR of transfusion-dependent (TDT) ß-thalassemia patients (n = 140) and normalized to non-transfusion-dependent (NTDT) ß-thalassemia (n = 45). Results revealed that plasma expression levels of miR-let-7d and miR-200b were significantly downregulated in TDT patients; however, miR-122 was upregulated. In terms of tissue iron load, aberrant expression of miRNAs was significantly associated with increased-iron accumulation in hepatic and cardiac tissues. We concluded that circulating miRNAs are strong candidates that associate iron hemostasis in transfusion-dependent ß-thalassemia major patients. And by extension, targeting miR-let-7d, miR-122, and miR-200 might serve as novel sensitive, specific and non-invasive predictor biomarkers for cellular damage under condition of tissue iron excess.


Subject(s)
Iron Overload/complications , MicroRNAs/blood , beta-Thalassemia/complications , Adolescent , Blood Transfusion , Case-Control Studies , Child , Child, Preschool , Female , Humans , Iron Overload/blood , Male , beta-Thalassemia/blood , beta-Thalassemia/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...